BRIEF published on 05/12/2025 at 17:40, 6 months 24 days ago Biotest confirme ses prévisions pour 2025 malgré une baisse de son chiffre d'affaires Biotest AG Baisse Des Revenus Risques Du Marché Collaboration Grifols Orientations 2025
BRIEF published on 05/12/2025 at 17:40, 6 months 24 days ago Biotest Confirms 2025 Guidance Amid Revenue Decline Revenue Decline Biotest AG Market Risks 2025 Guidance Grifols Collaboration
PRESS RELEASE published on 05/12/2025 at 17:35, 6 months 24 days ago Biotest confirms Guidance for 2025 Biotest confirms sales guidance for 2025 despite first quarter revenue decrease. EBIT decline attributed to lower sales and earnings from technology services Sales EBIT Guidance 2025 Biotest
BRIEF published on 03/31/2025 at 08:45, 8 months 5 days ago Biotest AG annonce sa radiation de la cote et une offre publique d'achat Grifols SA Biotest AG Bourse De Francfort Accord De Radiation Offre Aux Actionnaires
BRIEF published on 03/31/2025 at 08:45, 8 months 5 days ago Biotest AG Announces Delisting and Tender Offer Frankfurt Stock Exchange Grifols S.A. Biotest AG Shareholder Offer Delisting Agreement
PRESS RELEASE published on 03/31/2025 at 08:40, 8 months 5 days ago EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer Biotest AG has concluded a delisting agreement with major shareholder Grifols, S.A., initiating a delisting tender offer for its shares. The offer aims at revoking stock exchange admission Stock Exchange Tender Offer Biotest AG Delisting Agreement Grifols
BRIEF published on 03/31/2025 at 07:05, 8 months 5 days ago Biotest AG Sees 6% Sales Increase in 2024 Biotest AG 2025 Outlook 2024 Sales Yimmugo® Approval Fibrinogen Application
BRIEF published on 03/31/2025 at 07:05, 8 months 5 days ago Biotest AG prévoit une augmentation de ses ventes de 6 % en 2024 Biotest AG Perspectives 2025 Ventes 2024 Approbation Yimmugo® Application Du Fibrinogène
PRESS RELEASE published on 03/31/2025 at 07:00, 8 months 5 days ago Biotest AG increases sales by 6% in financial year 2024 Biotest AG reports 6% sales growth in 2024 financial year, achieving upper end of EBIT guidance. Significant approval milestones reached for key products Financial Report Sales Growth Biotest AG EBIT Guidance Approval Milestones
BRIEF published on 03/06/2025 at 09:06, 8 months 30 days ago Biotest AG's CFO Martin Möller to Depart Pharmaceuticals CFO Departure Biotest AG Grifols Group Martin Möller
Published on 12/05/2025 at 17:15, 47 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 2 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 2 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 17 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 2 hours 17 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 17:46, 15 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 1 minute ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 36 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 52 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 17:18, 44 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 44 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 51 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 51 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 3 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
